-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
May 01, 2017 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
May 01, 2017 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
May 01, 2017 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
May 01, 2017 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0129-fullreport.pdf
December 31, 2015 - Population – infants (29 days to 1 year) (specify age range): Yes; 29 days through 364
days.
q.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-139-fullreport.pdf
May 01, 2017 - Population – infants (29 days to 1 year) (specify age range): No.
q.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
January 17, 2017 - Peer reviewer #1 Results T in OSDB and sickle cell is not addressed
T in OSDB and infants is not addressed
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
January 17, 2017 - Peer reviewer #1 Results T in OSDB and sickle cell is not addressed
T in OSDB and infants is not addressed